Reaction
Diverticulitis Intestinal Perforated reporting signals
As of the last recalculation, Diverticulitis Intestinal Perforated appears in 323 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 165.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 23 | 165.4 | 165.8 |
| Remdesivir | 11 | 55.0 | 55.1 |
| Axicabtagene Ciloleucel | 5 | 33.1 | 33.2 |
| Tofacitinib Citrate | 6 | 30.0 | 30.0 |
| Axitinib | 8 | 27.1 | 27.1 |
| Cabozantinib | 12 | 16.7 | 16.7 |
| Bimekizumab | 4 | 12.2 | 12.2 |